BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic Encephalopathy: Diagnosis and Management. J Transl Int Med 2020;8:210-9. [PMID: 33511048 DOI: 10.2478/jtim-2020-0034] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sanchez-Meza F, Torre A, Castillo-Martinez L, Sanchez-Roman S, Morales-Buenrostro LE. Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests. Ren Fail 2021;43:577-84. [PMID: 33757399 DOI: 10.1080/0886022X.2021.1901740] [Reference Citation Analysis]
3 Ridola L, Riggio O, Gioia S, Faccioli J, Nardelli S. Clinical management of type C hepatic encephalopathy. United European Gastroenterol J 2020;8:536-43. [PMID: 32213035 DOI: 10.1177/2050640620909675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
5 Di Cola S, Nardelli S, Ridola L, Gioia S, Riggio O, Merli M. Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy. J Clin Med 2022;11:611. [PMID: 35160063 DOI: 10.3390/jcm11030611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. Clin Exp Hepatol 2020;6:116-24. [PMID: 32728628 DOI: 10.5114/ceh.2019.95105] [Reference Citation Analysis]
7 Ridola L, Riggio O, Gioia S, Nardelli S. Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis: Which comes first? Saudi J Gastroenterol 2020;26:111-2. [PMID: 32415046 DOI: 10.4103/sjg.SJG_169_20] [Reference Citation Analysis]
8 Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 2018; 24(48): 5446-5453 [PMID: 30622374 DOI: 10.3748/wjg.v24.i48.5446] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
9 Tagliapietra M, Monaco S. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations. Int J Mol Sci. 2020;21. [PMID: 32252497 DOI: 10.3390/ijms21072478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hontañón V, González-garcía J, Rubio-martín R, Díez C, Serrano-morago L, Berenguer J. Effect of HCV eradication on critical flicker frequency in HIV/HCV coinfected patients with advanced cirrhosis. Revista Clínica Española (English Edition) 2022. [DOI: 10.1016/j.rceng.2022.02.009] [Reference Citation Analysis]
11 Kimer N, Gluud LL, Pedersen JS, Tavenier J, Møller S, Bendtsen F. The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. Transl Gastroenterol Hepatol 2021;6:8. [PMID: 33409402 DOI: 10.21037/tgh.2020.02.14] [Reference Citation Analysis]
12 Ishida J, Oikawa T, Nakagawa C, Takano K, Fujioka K, Kikuchi Y, Tsuboi O, Ueda K, Nakano M, Saeki C, Torisu Y, Ikeda Y, Saruta M, Tsubota A. Real-time breath ammonia measurement using a novel cuprous bromide sensor device in patients with chronic liver disease: a feasibility and pilot study. J Breath Res 2021;15:026010. [PMID: 33527916 DOI: 10.1088/1752-7163/abb477] [Reference Citation Analysis]
13 Ridola L, Riggio O. Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic. J Clin Med 2021;10:298. [PMID: 33467479 DOI: 10.3390/jcm10020298] [Reference Citation Analysis]
14 Fortini I, Arouca EMG, Tengam FM, Nitrini R. Chronic HCV infection and neuropsychiatric dysfunction. eNeurologicalSci 2019;17:100206. [PMID: 31656863 DOI: 10.1016/j.ensci.2019.100206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol 2019; 25(35): 5257-5265 [PMID: 31558871 DOI: 10.3748/wjg.v25.i35.5257] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Tateyama M, Naoe H, Tanaka M, Tanaka K, Narahara S, Tokunaga T, Kawasaki T, Yoshimaru Y, Nagaoka K, Watanabe T, Setoyama H, Sasaki Y, Tanaka Y. Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study. BMC Gastroenterol 2020;20:371. [PMID: 33167879 DOI: 10.1186/s12876-020-01501-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Kartal A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Günşar F, Idilman R, Weissenborn K, Özütemiz Ö, Yurdaydin C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021. [PMID: 34085147 DOI: 10.1007/s12072-021-10207-5] [Reference Citation Analysis]
18 Han X, Luo Z, Wang W, Zheng P, Li T, Mei Z, Wang J. Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy. Front Pharmacol 2021;12:696065. [PMID: 34690751 DOI: 10.3389/fphar.2021.696065] [Reference Citation Analysis]
19 Ballester M, Gallego J, Fiorillo A, Casanova-ferrer F, Giménez-garzó C, Escudero-garcía D, Tosca J, Ríos M, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-miguel T, Kosenko E, Serra M, Felipo V, Montoliu C. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06416-z] [Reference Citation Analysis]